COMPANY
History
KHAV is a vaccine, therapeutics R&D and CRO company that contributes to human
and animal health through the development of next-generation vaccines.
-
- 2025
-
- Establishment of the Institutional Animal Care and Use Committee (IACUC)
-
- 2024
-
- Designated as a Livestock Disease Diagnostic Institution
- KHAV&KBNP R&D Investment Agreement Signed
- ND_Y280 CDMO Agreement Signed
- KHAV&KBNP Distribution Agreement Signed
- Manufacturing approval for veterinary pharmaceuticals and related products_PoulSafe
- Manufacturing approval for veterinary pharmaceuticals and related products_PoulGuard
- Obtained product approval and launched KHAV’s proprietary vaccines
-
- 2023
-
- Initiated CDMO operations for KHAV’s Proprietary Vaccines
- Designation as a Clinical Trial Institution for Veterinary Medical Devices
- Designated as a Wildlife Disease Diagnosis Institution
- Designated as an official Testing Institution for Veterinary Pharmaceuticals
- Concluded a technology export agreement with Vaksindo for the NDV vectored vaccine and related technologies
- Elkahmco Bio
- Baron Bio
- VIP Animal Medical Center
- Biotoxtech Co., Ltd.
- MOU Signings
-
- 2022
-
- SCL HealthCare
- CerntralBlo Inc.
- Signing MOU
-
- 2021
-
- Attracting capital investment by institutional investors (Intervest, BRIC, LOFTYROCK, SIMPAC, KG ZEROIN)
- License contract for ECLS mucosal adjuvant of EurCorVac-19 (COVID-19 Recombinant Protein Vaccine)
-
- 2020
-
- Certification of credit rating agencies
- Grant Agreement : Development of Recombinant Protein Antigen and Adjuvant Platform Technology for COVID-19 Preventive Vaccine (National Research Foundation of Korea)
- Grant Agreement : Development of SARS-CoV-2 recombinant vaccines as a nanogel formulationfor oral administration through sublingual routes (RIGHT FUND)
- Bionote Capital Investment Attraction
- Joint Technology Commercialization COVID-19 Vaccine Development Technology Agreement(BIONOTE Inc.)
-
- 2019
-
- Research service cooperation agreement for development of IB vaccine customized in Indonesia
-
- 2018
-
- Facility investment based on the establishment of a manufacturing plant
- Acquisition of medicine manufacturing license and factory registration
-
- 2017
-
- Certification of excellent technology evaluation companies
- Future Growth Engine Challenge Demo Day Excellence Award (Ministry of Science, ICT and Future Planning)
-
- 2016
-
- Grand Prize for Innovative Koreans & POWER KOREA R&D Division
- 2016 BRIDGE FESTIVAL Excellence Award
-
- 2015
-
- Establishment of KHAV Inc. laboratory
- Corporate affiliation laboratory recognition
-
- 2014
-
- Konkuk University Technology Holding Company Registration
- Establishment of KHAV Co.,Ltd